Cybin (HELP) Loans - Gross (2021 - 2023)

Cybin's (HELP) quarterly Loans - Gross came in at $145.4 million in Q2 2023, up 9690639.68% on a QoQ basis from $1500.3 in Q1 2023.

Cybin (HELP) Loans - Gross (2021 - 2023) Analysis & Trends

Cybin (HELP) has 2 years of Loans - Gross data on file, last reported at $145.4 million in Q2 2023.

Quarterly Loans - Gross changed N/A year-over-year to $145.4 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $145.4 million (changed N/A YoY) and the FY2023 annual result came in at $1541.7, changed N/A from the prior year.
Loans - Gross grew to $145.4 million in Q2 2023, from $1500.3 in the prior quarter.
In the past five years, Loans - Gross ranged from a high of $145.4 million in Q2 2023 to a low of $1500.3 in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Loans - Gross (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Cybin	417.29 Mn	417.29 Mn	-	-

Download Data